Donato NJ - Search Results

1

Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.

Perez-Soler R, Donato NJ, Shin DM, Rosenblum MG, Zhang HZ, Tornos C, Brewer H, Chan JC, Lee JS, Hong WK, et al. Perez-Soler R, et al. Among authors: donato nj. J Clin Oncol. 1994 Apr;12(4):730-9. doi: 10.1200/JCO.1994.12.4.730. J Clin Oncol. 1994. PMID: 8151316 Clinical Trial.

2

Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.

Donato NJ, Gallick GE, Steck PA, Rosenblum MG. Donato NJ, et al. J Biol Chem. 1989 Dec 5;264(34):20474-81. J Biol Chem. 1989. PMID: 2555361 Free article.

3

Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cells.

Mujoo K, Donato NJ, Lapushin R, Rosenblum MG, Murray JL. Mujoo K, et al. Among authors: donato nj. J Immunother Emphasis Tumor Immunol. 1993 Apr;13(3):166-74. doi: 10.1097/00002371-199304000-00003. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8471591

4

Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.

Donato NJ, Yan DH, Hung MC, Rosenblum MG. Donato NJ, et al. Cell Growth Differ. 1993 May;4(5):411-9. Cell Growth Differ. 1993. PMID: 8518234

5

Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.

Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksal H, Mendelsohn J, Hong WK. Shin DM, et al. Among authors: donato nj. Clin Cancer Res. 2001 May;7(5):1204-13. Clin Cancer Res. 2001. PMID: 11350885 Clinical Trial.

6

Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.

Donato NJ, Rosenblum MG, Steck PA. Donato NJ, et al. Cell Growth Differ. 1992 May;3(5):259-68. Cell Growth Differ. 1992. PMID: 1378752

7

Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.

Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donato NJ. Nishikawa K, et al. Among authors: donato nj. Cancer Res. 1992 Sep 1;52(17):4758-65. Cancer Res. 1992. PMID: 1380890

8

Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.

Donato NJ, Rotbein J, Rosenblum MG. Donato NJ, et al. J Cell Biochem. 1991 May;46(1):69-77. doi: 10.1002/jcb.240460111. J Cell Biochem. 1991. PMID: 1874802

9

Characterization of human recombinant tumor necrosis factor-alpha antiproliferative effects on human cells in culture.

Rosenblum MG, Donato NJ, Gutterman JU. Rosenblum MG, et al. Among authors: donato nj. Lymphokine Res. 1988 Summer;7(2):107-17. Lymphokine Res. 1988. PMID: 2457138

10

Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.

Donato NJ, Ince C, Rosenblum MG, Gallick GE. Donato NJ, et al. J Cell Biochem. 1989 Nov;41(3):139-57. doi: 10.1002/jcb.240410305. J Cell Biochem. 1989. PMID: 2482293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters